[1]彭文林,蹇朝,刘超,等.循环环状RNA hsa_circ_0029642与成人先天性心脏病肺动脉高压的关系[J].第三军医大学学报,2017,39(10):1005-1008.
 Peng Wenlin,Jian Zhao,Liu Chao,et al.Correlation of circular RNA hsa_circ_0029642 with pulmonary hypertension in adult patients with congenital heart disease[J].J Third Mil Med Univ,2017,39(10):1005-1008.
点击复制

循环环状RNA hsa_circ_0029642与成人先天性心脏病肺动脉高压的关系(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
39卷
期数:
2017年第10期
页码:
1005-1008
栏目:
临床医学
出版日期:
2017-05-30

文章信息/Info

Title:
Correlation of circular RNA hsa_circ_0029642 with pulmonary hypertension in adult patients with congenital heart disease
作者:
彭文林蹇朝刘超孟永胜朱昀姜云瀚罗桂平唐富琴肖颖彬
第三军医大学新桥医院全军心血管外科研究所
Author(s):
Peng Wenlin Jian Zhao Liu Chao Meng Yongsheng Zhu Yun Jiang Yunhan Luo Guiping Tang Fuqin Xiao Yingbin 

Institute of Cardiovascular Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China

关键词:
循环环状RNA先天性心脏病肺动脉高压
Keywords:
circular RNA congenital heart disease pulmonary hypertension
分类号:
R446.11; R541.1; R543.2
文献标志码:
A
摘要:

目的      检测血清中环状RNA hsa_circ_0029642的含量,明确其与肺动脉高压是否有密切关系,探讨循环环状RNA hsa_circ_0029642作为肺动脉高压血清标志物的可能性。方法      收集2016年3-7月入院的先天性心脏病伴肺动脉高压患者血清20例(A组),先天性心脏病不伴肺动脉高压患者血清20例(B组),风湿性心脏病伴肺动脉高压患者血清20例(C组),各组从血清中提取总 RNA 并进行质量检测,进行反转录反应,获得相应的cDNA,以GAPDH作为内参进行标定,进行实时荧光定量 PCR 反应,根据各样本的定量 PCR 结果计算RQ值,绘制 ROC 曲线。结果      3组样本的总 RNA 均有较好的质量,A组与C组的RQ值差异无统计学意义(P>0.05),A组与B组的RQ值差异有统计学意义(P<0.05),B组与C组的RQ值差异有统计学意义(P<0.01)。即A组和C组的RQ值显著低于B组,而A组与C组的RQ值差异无统计学意义。ROC曲线(曲线下面积AUC=0.752,P<0.01,95%CI:0.624~0.884)。结论     先天性心脏病肺动脉高压患者血清中环状RNA hsa_circ_0029642明显下调,循环环状RNA hsa_circ_0029642可作为肺动脉高压新的血清标志物。

Abstract:

Objective      To investigate the correlation between serum level of circular RNA hsa_circ_0029642 and pulmonary hypertension in adult patients with congenital heart disease and explore the possibility of using hsa_circ_0029642 as a serum marker of pulmonary hypertension. Methods      Serum samples were collected from 20 patients with congenital heart disease and concurrent pulmonary hypertension (group A), 20 patients with congenital heart disease but without pulmonary hypertension (group B), and 20 patients with rheumatic heart disease and pulmonary hypertension (group C). The total RNA was extracted from the serum samples for reverse transcription to obtain the corresponding cDNA. Real-time fluorescent quantitative PCR reaction was performed to detect the levels of circular RNA hsa_circ_0029642 with GAPDH as the internal control. The RQ value was calculated and the ROC curve was mapped based on the results of quantitative PCR to assess the value of hsa_circ_0029642 in the diagnosis of pulmonary arterial hypertension. Results      The total RNA extracted from the serum samples all had good quality in the 3 groups. The RQ value differed significantly between groups A and B (P<0.05)and between groups B and group C (P<0.01), but not between groups A and C (P>0.05); the RQ value was significantly lower in groups A and C than in group B, and was comparable between groups A and C. Analysis of the ROC curve showed that the serum level of hsa_circ_0029642 had an area under the curve (AUC) of 0.752 (95%CI:0.624~0.884,P<0.01) for the diagnosis of pulmonary arterial hypertension. Conclusion      The serum level of circular RNA hsa_circ_0029642 is obviously lowered in patients with congenital heart disease and concurrent pulmonary arterial hypertension and can be used as a new serum marker for pulmonary hypertension.

参考文献/References:

[1]Roth T S, Aboulhosn J A. Pulmonary Hypertension and Congenital Heart Disease[J]. Cardiol Clin, 2016, 34(3): 391-400. DOI: 10.1016/j.ccl.2016.04.002.
[2]Montani D, Chaumais M C, Guignabert C, et al. Targeted therapies in pulmonary arterial hypertension[J]. Pharmacol Ther, 2014, 141(2): 172-191. DOI: 10.1016/j. pharmthera.2013.10.002.
[3]D’Alto M, Dimopoulos K, Budts W, et al. Multimodality imaging in congenital heart diseaserelated pulmonary arterial hypertension[J]. Heart, 2016, 102(12): 910-918. DOI: 10.1136/heartjnl2015308903.
[4]Salzman J. Circular RNA Expression: Its Potential Regulation and Function[J]. Trends Genet, 2016, 32(5): 309-316. DOI: 10.1016/j.tig.2016.03.002.
[5]Memczak S, Papavasileiou P, Peters O, et al. Identification and Characterization of Circular RNAs As a New Class of Putative Biomarkers in Human Blood[J]. PLoS ONE, 2015, 10(10): e0141214. DOI: 10.1371/journal.pone.0141214.
[6]D’Alto M, Romeo E, Argiento P, et al. Pulmonary arterial hypertension: the key role of echocardiography[J]. Echocardiography, 2015, 32(Suppl 1): S23-S37. DOI:10.1111/echo.12283.
[7]Qu S, Yang X, Li X, et al. Circular RNA: A new star of noncoding RNAs[J]. Cancer Lett, 2015, 365(2): 141-148.  DOI: 10.1016/j.canlet.2015.06.003.
[8]Meng X, Li X, Zhang P, et al. Circular RNA: an emerging key player in RNA world[J]. Briefings in bioinformatics, 2016:bbw045. DOI:10.1093/bib/bbw045.
[9]Hansen T B, Jensen T I, Clausen B H, et al. Natural RNA circles function as efficient microRNA sponges[J]. Nature, 2013, 495(7441): 384-388. DOI: 10.1038/nature11993.
[10]Wang K, Long B, Liu F, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR223[J]. Eur Heart J, 2016, 37(33): 2602-2611. DOI: 10.1093/eurheartj/ehv713.
[11]Groth A, Vrugt B, Brock M, et al. Inflammatory cytokines in pulmonary hypertension[J]. Respiratory research, 2014, 15(1): 1.
[12]Crosswhite P, Sun Z. Molecular mechanisms of pulmonary arterial remodeling[J]. Mol Med, 2014, 20: 191-201. DOI:10.2119/molmed.2013.00165.
[13]Owens G K, Kumar M S, Wamhoff B R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84(3): 767-801. DOI: 10.1152/physrev.00041.2003.
[14]Fei J, Cui X B, Wang J N, et al. ADAR1Mediated RNA Editing, A Novel Mechanism Controlling Phenotypic Modulation of Vascular Smooth Muscle Cells[J]. Circ Res, 2016,119(3): 463-469. DOI: 10.1161/CIRCRESAHA.116.309003.
[15]Rabinovici R, Kabir K, Chen M, et al. ADAR1 is involved in the development of microvascular lung injury[J]. Circ Res, 2001, 88(10): 1066-1071. DOI: 10.1161/hh1001.090877.
[16]RybakWolf A, Stottmeister C, Glaar P, et al. Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed[J]. Mol Cell, 2015, 58(5): 870-885. DOI: 10.1016/j.molcel.2015.03.027.
[17]Xia S J,Tai X T,Li B,et al.Study of circular RNA expression profile of lungs in the mice with hypoxiainduced pulmonary hypertension[J]. Chin J Lung Dis(Electronic Edition), 2015, 8(1): 34-38.
[18]Cheng I K, Ching A K, Chan T C, et al. Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis[J]. J Pathol, 2010, 220(3): 348-360. DOI: 10.1002/path.2644.

相似文献/References:

[1]许敏,吴晓云,李勇刚,等.CITED2基因CpG岛甲基化与先天性心脏病的关系[J].第三军医大学学报,2013,35(03):245.
 Xu Min,Wu Xiaoyun,Li Yonggang,et al.Relationship of CpG islands methylation of CITED2 and congenital heart disease[J].J Third Mil Med Univ,2013,35(10):245.
[2]李永华,张志辉,冉擘力,等.经导管封堵对先天性心脏病伴肺动脉高压患者血浆脑钠素的影响及其药物干预研究[J].第三军医大学学报,2008,30(04):345.
 I Yong-hua,ZHANG Zhi-hui,RAN Bo-li,et al.Effects of Enalapril or Metoprolol on plasm brain natriuretice peptide in congenital heart disease combined with pulmonary artery hypertension after transcatheter closure[J].J Third Mil Med Univ,2008,30(10):345.
[3]钟理,宋治远,冉擘力,等.先天性巨大冠状动脉右室瘘的介入治疗[J].第三军医大学学报,2008,30(04):348.
 ZHONG Li,SONG Zhi-yuan,RAN Bo-li,et al.Transcatheter closure of giant congenital coronary artery fistula with patent duct occluder[J].J Third Mil Med Univ,2008,30(10):348.
[4]唐旭东,肖颖彬,周建国,等.Survivin在先天性心脏病肺动脉高压发生机制中的作用[J].第三军医大学学报,2008,30(01):27.
 TANG Xu-dong,XIAO Ying-bin,ZHOU Jian-guo,et al.Role of survivin in pulmonary hypertension of congenital heart disease[J].J Third Mil Med Univ,2008,30(10):27.
[5]徐红珍,杨利群,叶茂,等.5 kg以下婴儿先天性心脏病体外循环管理[J].第三军医大学学报,2006,28(05):478.
[6]舒茂琴,宋治远,钟理,等.动脉导管未闭合并感染性心内膜炎的介入治疗[J].第三军医大学学报,2006,28(13):1432.
[7]杨望,廖伟,赵聪敏.西地那非治疗婴幼儿先天性心脏病重度肺动脉高压疗效观察[J].第三军医大学学报,2011,33(15):1623.
 Yang Wang,Liao Wei,Zhao Congmin.Therapeutic effect of sildenafil on severe pulmonary arterial hypertension associated with congenital heart disease in infants[J].J Third Mil Med Univ,2011,33(10):1623.
[8]张智睿,陈沅,向平,等.血清NT-proBNP在青紫型先天性心脏病患儿中的临床意义[J].第三军医大学学报,2010,32(17):1880.
 Zhang Zhirui,Chen Yuan,Xiang Ping,et al.Clinical significance of serum N-terminal pro-brain natriuretic peptide in children with cyanotic congenital heart disease[J].J Third Mil Med Univ,2010,32(10):1880.
[9]郑光美,朱方成,白姣,等.超声诊断右旋心合并复杂心血管畸形1例[J].第三军医大学学报,2010,32(08):797.
[10]宫婷,李芬,Huang Hui,等.MTR、MTRR基因多态性与先天性心脏病的相关性研究[J].第三军医大学学报,2010,32(02):127.
 Gong Ting,Li Fen,Huang Hui,et al.Relationship of maternal and child polymorphism in methionine synthetase and methionine synthase reductase with congenital heart disease[J].J Third Mil Med Univ,2010,32(10):127.

更新日期/Last Update: 2017-05-22